Ameritas Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$934K Sell
7,390
-938
-11% -$124K 0.02% 578
2026
Q1
$1.16M Sell
8,328
-6,397
-43% -$896K 0.05% 337
2025
Q4
$1.81M Buy
14,725
+12,841
+682% +$1.56M 0.07% 242
2025
Q3
$209K Sell
1,884
-3,608
-66% -$410K 0.01% 605
2025
Q2
$609K Buy
5,492
+616
+13% +$65.6K 0.03% 457
2025
Q1
$511K Buy
4,876
+96
+2% +$9.91K 0.02% 563
2024
Q4
$442K Sell
4,780
-760
-14% -$68.4K 0.02% 622
2024
Q3
$464K Buy
5,540
+348
+7% +$26.6K 0.02% 560
2024
Q2
$356K Sell
5,192
-2,167
-29% -$145K 0.01% 683
2024
Q1
$518K Buy
7,359
+1,474
+25% +$113K 0.02% 545
2023
Q4
$461K Buy
5,885
+177
+3% +$13.8K 0.03% 445
2023
Q3
$428K Buy
+5,708
New +$439K 0.02% 539
2023
Q2
Sell
-7,564
Closed -$647K 1337
2023
Q1
$647K Sell
7,564
-3,369
-31% -$279K 0.03% 421
2022
Q4
$939K Buy
10,933
+2,052
+23% +$162K 0.04% 367
2022
Q3
$548K Buy
8,881
+585
+7% +$36.9K 0.03% 410
2022
Q2
$513K Buy
8,296
+46
+0.6% +$2.85K 0.03% 445
2022
Q1
$490K Buy
8,250
+1,044
+14% +$66.7K 0.02% 506
2021
Q4
$523K Buy
+7,206
New +$496K 0.02% 493

Other funds holding GILD

Ameritas Advisory Services's GILD Position: Q2 2026 in Review

Ameritas Advisory Services reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $124K and leaving 7,390 shares worth $934K. The position accounts for 0.02% of the portfolio, ranked #578.

Ameritas Advisory Services first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.81M in Q4 2025. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ameritas Advisory Services held 7,390 shares of Gilead Sciences worth $934K as of Q2 2026.
  • Ameritas Advisory Services sold 938 Gilead Sciences shares in Q2 2026, an estimated $124K.
  • Gilead Sciences made up 0.02% of Ameritas Advisory Services's portfolio in Q2 2026, its #578 holding.
  • Ameritas Advisory Services first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • Ameritas Advisory Services's Gilead Sciences position peaked at $1.81M in Q4 2025.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.